Potent and selective bicyclic lactam inhibitors of thrombin: Part 2: P1 modifications

被引：24
|
作者：
Plummer, JS [1 ]
Berryman, KA
Cai, C
Cody, WL
DiMaio, J
Doherty, AM
Edmunds, JJ
He, JX
Holland, DR
Levesque, S
Kent, DR
Narasimhan, LS
Rubin, JR
Rapundalo, ST
Siddiqui, MA
Susser, AJ
St-Denis, Y
Winocour, PD
机构：
[1] Parke Davis Pharmaceut Res, Ann Arbor, MI 48105 USA
[2] BioChem Therapeut Inc, Laval, PQ H7V 4A7, Canada
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1998年 / 8卷 / 23期
关键词：
D O I：
10.1016/S0960-894X(98)00613-1
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
The synthesis and antithrombotic activity of a series of nonpeptide bicyclic thrombin inhibitors is described. We have explored the SAR with modifications to the pi site. The introduction of arginine mimetics at the pi site led to potent and selective thrombin inhibitors. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码：3409 / 3414
页数：6
相关论文
共 50 条
  • [41] CHARACTERIZATION OF A CLASS OF PEPTIDE BORONATES WITH NEUTRAL P1 SIDE-CHAINS AS HIGHLY SELECTIVE PRODRUG INHIBITORS OF THROMBIN
    DEADMAN, J
    ELGENDY, S
    GOODWIN, C
    GREEN, D
    BABAN, J
    PATEL, G
    SKORDALAKES, E
    CHINO, N
    CLAESON, G
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 924 - 924
  • [42] Potent carboxylate inhibitors of stromelysin containing P2' piperazic acids and P1' biaryl moeities
    Cherney, RJ
    Decicco, CP
    Nelson, DJ
    Wang, L
    Meyer, DT
    Hardman, KD
    Copeland, RA
    Arner, EC
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (13) : 1757 - 1762
  • [43] Design of P1′ and P3′ residues of trivalent thrombin inhibitors and their crystal structures
    Sion-Usakiewicz, JJ
    Sivaraman, J
    Li, YG
    Cygler, M
    Konishi, Y
    BIOCHEMISTRY, 2000, 39 (09) : 2384 - 2391
  • [44] In vitro and in vivo properties of bicyclic lactam inhibitors: A novel class of low molecular weight peptidomimetic thrombin inhibitors
    Leblond, L
    Grouix, B
    Boudreau, C
    Yang, Q
    Siddiqui, MA
    Winocour, PD
    THROMBOSIS RESEARCH, 2000, 100 (03) : 195 - 209
  • [45] Proteinase inhibitors from desert locust, Schistocerca gregaria:: engineering of both P1 and P1′ residues converts a potent chymotrypsin inhibitor to a potent trypsin
    Malik, Z
    Amir, S
    Pál, G
    Buzás, Z
    Varallyay, É
    Antal, J
    Szilágyi, Z
    Vékey, K
    Asbóth, B
    Patthy, A
    Gráf, L
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 1999, 1434 (01): : 143 - 150
  • [46] STRUCTURE-FUNCTION ASPECTS OF NEUTRAL P1 RESIDUE PEPTIDE INHIBITORS OF THROMBIN
    DEADMAN, J
    CLAESON, G
    SCULLY, MF
    JOURNAL OF ENZYME INHIBITION, 1995, 9 (01): : 29 - 41
  • [47] Noncovalent tripeptidic thrombin inhibitors incorporating amidrazone, amine and amidine functions at P1
    Lee, K
    Jung, WH
    Park, CW
    Park, HD
    Lee, SH
    Kwon, OH
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (07) : 1017 - 1022
  • [48] Design and synthesis of potent and selective macrocyclic thrombin inhibitors.
    Nantermet, PG
    Barrows, JC
    Newton, CL
    Pellicore, JM
    Young, MB
    Lewis, SD
    Lucas, BJ
    Krueger, JA
    McMasters, DR
    Yan, YW
    Kuo, LC
    Vacca, J
    Selnick, HG
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U203 - U204
  • [49] Design and synthesis of potent and selective macrocyclic thrombin inhibitors.
    Pellicore, JM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U214 - U214
  • [50] Studies towards the identification of potent, selective and bioavailable thrombin inhibitors
    Ambler, J
    Baker, E
    Bentley, D
    Brown, L
    Butler, K
    Butler, P
    Farr, D
    Dunnet, K
    Le Grand, D
    Hayler, J
    Janus, D
    Jones, D
    Menear, K
    Mercer, M
    Smith, G
    Talbot, M
    Tweed, M
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (05) : 737 - 742
12345